Join medical device and digital health entrepreneurs, CEOs of venture-backed companies, and business development executives from large Medtech and digital health companies, as well as angels, venture capitalists, and...more
5/8/2025
/ Acquisitions ,
Antitrust Violations ,
Artificial Intelligence ,
CEOs ,
Digital Health ,
Emerging Growth Companies ,
Equity Compensation ,
Events ,
Executive Compensation ,
Exit Strategies ,
Food and Drug Administration (FDA) ,
Innovation ,
Investors ,
Med Tech ,
Medical Devices ,
Mergers ,
Patents ,
Startups ,
Venture Capital
This issue features articles on the firm’s Business Advisory Practice supporting Nervosave Therapeutics’ U.S. expansion; the USPTO’s forthcoming guidance on AI innovation protection; option pool sizes for life sciences...more
Wilson Sonsini is pleased to present the latest edition of The Life Sciences Report. This issue features articles on the firm’s new Boulder office and recent Gateway to Colorado VC roadshow, a collaboration between Deloitte’s...more
Wilson Sonsini is pleased to present the latest edition of The Life Sciences Report. This issue features an interview with Foresight Diagnostics co-founder and CEO Jake Chabon conducted by Matthew Meyer, the firm’s Chief...more